United Therapeutics Corp (UTHR) Reports Q4 EPS of $0.79, Reaffirms FY12, FY13 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 598.72 +5.18 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $593.54 | 52 Week High | $164.04 | |||
| Open | $600.00 | 52 Week Low | $97.52 | |||
| Day High | $609.99 | P/E | 109.46 | |||
| Day Low | $593.57 | EPS | $5.47 | |||
| Volume | 518,240 | |||||
